# Outcomes of the Electrothermal Bipolar Vessel Sealing Device and Electrocautery in Modified Radical Mastectomy Patients

**Authors:** Ravindran Chirukandath, Sancia R Fernandez, Sharath K Krishnan, Sumin V Sulaiman, Daniel Suting, Soorya Gayathry P., Sreeparvathy R Nair

PMC · DOI: 10.7759/cureus.62371 · 2024-06-14

## TL;DR

This study compares electrothermal bipolar vessel sealing and electrocautery in mastectomy surgeries, finding faster operation times but no difference in postoperative complications.

## Contribution

A comparative analysis of EBVS and electrocautery in modified radical mastectomy using intraoperative and postoperative outcomes.

## Key findings

- EBVS reduced total operative time, dissection times, and blood loss compared to electrocautery.
- Postoperative drainage volume and duration were lower in the EBVS group.
- No significant difference in seroma formation or postoperative complications between the two groups.

## Abstract

Introduction

With the rising trends in breast cancer throughout the world, the traditional modus of intraoperative tissue dissection using a scalpel, scissors, or electrocautery needs to be re-evaluated in the wake of newer modalities, such as electrothermal bipolar vessel sealing (EBVS) devices, which may theoretically reduce the postoperative complications and morbidity in these patients.

Aim and objective

The objective of this study is to compare an EBVS device to electrocautery (diathermy) in modified radical mastectomy (MRM), based on selected intraoperative and postoperative outcomes.

Study procedure

This was a comparative cross-sectional section study that included 60 patients with operable breast cancer (stages I and II, TNM classification, and post-neoadjuvant stage III disease). Patients were divided into two groups for surgery: one group underwent an MRM using the EBVS device (Group A), while the other group had the procedure performed using conventional electrocautery (Group B), as per the surgeon’s choice depending on theatre slot and equipment availability. Intraoperatively, the total operative time, time for raising the flaps, time taken for breast tissue dissection, time for axillary dissection, and blood loss were recorded. Postoperative parameters included total drainage volume, number of days of drainage, seroma formation, and other complications. Patients were followed up for one month after surgery, with early postoperative complications such as wound infection, upper limb lymphedema, seroma, flap necrosis, and nerve injuries being documented.

Results

The groups were found to be comparable in terms of the age distribution, TNM staging, stage grouping, and nodal status of the patients. The EBVS device group demonstrated statistically significant advantages in total operative time, axillary dissection time, flap raising time, breast tissue dissection time, intraoperative blood loss, total drainage volume, and days of drainage. However, no statistically significant difference was found between the two devices in terms of seroma formation, early postoperative complications, and duration of postoperative stay at the hospital.

Conclusion

While the use of EBVS in MRM provides a considerable decrement in the total operative duration, duration of the various steps of surgery, intraoperative blood loss, and postoperative volume and duration of drainage, these devices do not offer an evident advantage in terms of the postoperative complications or morbidity.

## Linked entities

- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** TENM1 (teneurin transmembrane protein 1) [NCBI Gene 10178] {aka ODZ1, ODZ3, TEN-M1, TEN1, TNM, TNM1}
- **Diseases:** stage III disease (MESH:D007676), breast cancer (MESH:D001943), Postoperative (MESH:D019106), flap necrosis (MESH:D000070600), lymphedema (MESH:D008209), wound infection (MESH:D014946), seroma (MESH:D049291), nerve injuries (MESH:D000080902), postoperative complications (MESH:D011183)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11246779/full.md

---
Source: https://tomesphere.com/paper/PMC11246779